Transcranial Photobiomodulation (tPBM) Treatment for Autism Spectrum Disorder
This trial will test a new treatment for ASD and measure its safety, tolerability, and effectiveness.
- Autism Spectrum Disorder
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there openings for individuals to participate in the trial?
"Clinicaltrials.gov informs us that this medical trial is currently seeking participants; the original posting date was February 11th, 2022 and it has been recently amended on May 2nd, 2022."
How extensive is the participant pool for this medical experiment?
"Affirmative. According to clinicaltrials.gov, this research project is on the hunt for 54 volunteers from one medical centre and was initially posted on February 11th 2022 with recent edits dated May 2nd 2022."
What is the ultimate goal of this research endeavor?
"The primary aim of this trial, which is set to last an average of 8 weeks, will evaluate the change in ASD symptoms based on scores from the Social Responsiveness Scale-2nd Edition (SRS-2). Assessments related to treatment's effect on associated psychopathology such as Attention Deficit Hyperactivity Disorder (ADHD) and social cognition functions will be conducted with the Clinical Global Impression of Improvement in ADHD scale (CGI-ADHD-I), Massachusetts General Hospital Social Emotional Competence Scale (MGH-SEC Scale), and Behavior Rating Inventory of Executive Function - Adult Self Report Version (BRIEF-"
Does your research encompass elderly individuals aged 85 years and above?
"Eligible individuals for this trial must be between 18 and 59 years old."
Could I become a participant in this medical experiment?
"With the goal of recruiting 54 participants, this trial is seeking individuals between 18 and 59 years old with autism spectrum disorder. Interested applicants must meet certain requirements such as: being able to comprehend the study's purpose; possessing a valid decision-making capacity; having an SRS raw score no less than 85 combined with CGI-ASD severity score equal or above 4; conforming to Diagnostic and Statistical Manual-5th edition diagnostic criteria for Autism Spectrum Disorder (DSM 5) established by clinical diagnostic interview; displaying sufficient communication capabilities in order to collaborate effectively with investigators/study coordinators involved in the project. Furthermore, if female potential"